Search research articles
Contact Us
Filters
Showing results (1381-1390 of 3,162) with videos related to
Page
of 317
Sort By:
Muscle & Nerve
|
September 29, 2011
Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation
Alberto Dubrovsky, Jose Corderi, Min Lin, et al.
Diagnostic Microbiology and Infectious Disease
|
August 20, 2011
Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010)
Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
February 10, 2006
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)
Paul R Rhomberg, Thomas R Fritsche, Helio S Sader, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 26, 2006
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol
R N Jones, T R Fritsche, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
March 21, 2006
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003)
David M Johnson, Matthew G Stilwell, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease
|
February 23, 2002
Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program
Ronald N Jones, Phyllis Della-Latta, Lillian V Lee, et al.
The EMBO Journal
|
February 2, 1999
Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus
D J Mann, E S Child, C Swanton, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1995
Antigonococcal activity of 11 drugs used for therapy or prophylaxis of malaria
P C Mehaffey, M S Barrett, S D Putnam, et al.
Diagnostic Microbiology and Infectious Disease
|
August 18, 2004
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates
Helio S Sader, Jennifer M Streit, Thomas R Fritsche, et al.
Antimicrobial Agents and Chemotherapy
|
May 25, 2004
Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001
K J Christiansen, J M Bell, J D Turnidge, et al.
Page
of 317
Search research articles
Search
Showing results (1381-1390 of 3,162) with videos related to
Sort By:
Page
of 317
Muscle & Nerve
|
September 29, 2011
Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation
Alberto Dubrovsky, Jose Corderi, Min Lin, et al.
Diagnostic Microbiology and Infectious Disease
|
August 20, 2011
Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010)
Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
February 10, 2006
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)
Paul R Rhomberg, Thomas R Fritsche, Helio S Sader, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 26, 2006
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol
R N Jones, T R Fritsche, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
March 21, 2006
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003)
David M Johnson, Matthew G Stilwell, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease
|
February 23, 2002
Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program
Ronald N Jones, Phyllis Della-Latta, Lillian V Lee, et al.
The EMBO Journal
|
February 2, 1999
Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus
D J Mann, E S Child, C Swanton, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1995
Antigonococcal activity of 11 drugs used for therapy or prophylaxis of malaria
P C Mehaffey, M S Barrett, S D Putnam, et al.
Diagnostic Microbiology and Infectious Disease
|
August 18, 2004
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates
Helio S Sader, Jennifer M Streit, Thomas R Fritsche, et al.
Antimicrobial Agents and Chemotherapy
|
May 25, 2004
Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001
K J Christiansen, J M Bell, J D Turnidge, et al.
Page
of 317